Cornerstone Planning Group’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-23
Closed -$1.65K – 1525
2026
Q2
$1.65K Sell
23
-64
-74% -$3.46K ﹤0.01% 1373
2026
Q1
$4.88K Buy
87
+12
+16% +$720 ﹤0.01% 1091
2025
Q4
$4.92K Sell
75
-27
-26% -$1.64K ﹤0.01% 992
2025
Q3
$788 Buy
102
+22
+28% +$1.18K ﹤0.01% 1369
2025
Q2
$4.37K Buy
80
+62
+344% +$3.12K ﹤0.01% 756
2025
Q1
$903 Sell
18
-12
-40% -$813 ﹤0.01% 1162
2024
Q4
$2.29K Buy
30
+26
+650% +$1.91K ﹤0.01% 761
2024
Q3
$283 Sell
4
-10
-71% -$751 ﹤0.01% 1209
2024
Q2
$1.09K Buy
+14
New +$1.03K ﹤0.01% 917
2022
Q4
$1.62K Buy
+20
New +$1.59K ﹤0.01% 1246

Other funds holding TECH

Cornerstone Planning Group's TECH Position: Q3 2026 in Review

Cornerstone Planning Group sold out of Bio-Techne (TECH) in Q3 2026, closing a stake of 23 shares — an estimated $1.65K sold.

Cornerstone Planning Group first reported a position in TECH in Q4 2022 and held it in 10 quarters. The position peaked at $4.92K in Q4 2025. 65 funds tracked by Wall St. Rank hold TECH as of Q3 2026.

  • Cornerstone Planning Group reported no remaining Bio-Techne position as of Q3 2026 after selling out during the quarter.
  • Cornerstone Planning Group sold 23 Bio-Techne shares in Q3 2026, an estimated $1.65K.
  • Cornerstone Planning Group first reported a position in Bio-Techne in Q4 2022 and held it in 10 quarters.
  • Cornerstone Planning Group's Bio-Techne position peaked at $4.92K in Q4 2025.
  • 65 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2026.

Based on Cornerstone Planning Group's 13F filing for Q3 2026, filed 16 Oct 2026.